HAFNER ANDREAS,BLATTER FRITZ,SZELAGIEWICZ MARTIN,SIEBENHAAR BERND,CHIODO TIZIANA,HINTERMANN TOBIAS,SALVADOR BEATE,VOSSEN MARCUS
申请号：
IN201647005802
公开号：
IN201647005802A
申请日:
2016.02.19
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention primarily relates to molecular crystalline substances preferably salts of Dasatinib in crystalline form comprising a compound of formula 1 preferably a cation of a compound of formula 1 and a second compound selected from the group consisting of glutaric acid nicotinic acid and saccharin preferably an anion thereof. The invention is further related to pharmaceutical compositions comprising such a substance. Furthermore the invention relates to processes for preparing said substances. The invention also relates to several aspects of using said substances or pharmaceutical compositions to treat a disease.
